Adult-Type Diffuse Glioma — Trials

Adult-Type Diffuse Glioma — Trials · CancerIndex

Clinical trials

Registered studies

1,869 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 510
Recruiting: 275
Ph III recruiting: 18
Growth YoY: +40.7%
Industry share: 19%
Top sponsor: National Cancer Institute (NCI)
Termination share: 34.1%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (296)

clinicaltrialsPublishedShowing 1–50 of 161 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04729959	Testing the Addition of the Immune Therapy Drugs, Tocilizumab and Atezolizumab, to Radiation Therapy for Recurrent Glioblastoma	active not recruiting	Phase 2	61	National Cancer Institute (NCI)NIH	1	Sep 23, 2026	clinicaltrials
NCT05353530	IL-8 Receptor-modified CD70 CAR T Cell Therapy in CD70+ Adult Glioblastoma(IMPACT)	active not recruiting	Phase 1	39	University of FloridaOTHER	1	Sep 23, 2026